Recent Updates
Recently added Catalysts

Activity Tracking Watch

Phase 1

Healthy | Unknown | Other |Merck & Company, Inc.|Last Updated: Feb 19, 2025

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
UNCONTROLLEDBiomarker
Total Trials1
Total Enrollment12
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT06833879Activity Tracking Study in Healthy Volunteers (MK-0000-419)PHASE1 COMPLETED 12May 12, 2022Jun 16, 2022Feb 19, 20252 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Number of Participants that Wear Watch as Instructed
Up to approximately 2 weeks

The number of participants that wear the watch for at least 19.2 hours per day (80% of the time) will be reported.

Number of Provisioned Watches and Data Storage Devices That Were Returned
Up to approximately 2 weeks

The number of watches and data storage devices provisioned and returned free from malfunction will be reported.

Number of Watches and Data Storage Devices that Successfully Transmit Data
Up to approximately 2 weeks

The number of watches and data storage devices that successfully transmit data to central database will be reported.

Average Daily Overall Activity Count
Up to approximately 2 weeks

The average daily overall activity will be reported.

Average Daily Total Step Count
Up to approximately 2 weeks

The number of average daily total steps will be reported.

Average Daily Time (minutes) in Nonsedentary Activity
Up to approximately 2 weeks

The average daily time spent in nonsedentary activity will be reported.

Average Daily Time (minutes) in Moderate-to-Vigorous Physical Activity
Up to approximately 2 weeks

The average daily time spent in moderate-to-vigorous physical activity will be reported.

Secondary Endpoints
Number of Participants Who Experience an Adverse Event (AE)
Up to approximately 2 weeks
Number of Participants Who Discontinue Study Intervention Due to an AE
Up to approximately 2 weeks
Unlock Study Endpoints
Study Design & Arms
AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeBASIC_SCIENCE
Treatment Arms
ArmTypeDescription
Watch Wearing to Track ActivityEXPERIMENTALParticipants wear a watch that tracks physical activity throughout study.
Interventions
NameTypeDescription
Activity Tracking WatchDEVICEDevice includes a wristwatch that tracks physical activity and a data storage unit that transmits data to a central database.
Unlock Study Design Details
Eligibility Criteria
Age Range40 Years — 75 Years
SexALL
Healthy VolunteersYes
Study Sites2

Inclusion Criteria: The key inclusion criteria include but are not limited to: * Is in good health * Is willing to comply with study restrictions Exclusion Criteria: The key exclusion criteria include but are not limited to: * History of clinically significant endocrine, GI, cardiovascular, hem...

Countries:United States
Unlock Eligibility Criteria